1. Home
  2. CPRX vs CALX Comparison

CPRX vs CALX Comparison

Compare CPRX & CALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • CALX
  • Stock Information
  • Founded
  • CPRX 2002
  • CALX 1999
  • Country
  • CPRX United States
  • CALX United States
  • Employees
  • CPRX N/A
  • CALX N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • CALX Telecommunications Equipment
  • Sector
  • CPRX Health Care
  • CALX Consumer Discretionary
  • Exchange
  • CPRX Nasdaq
  • CALX Nasdaq
  • Market Cap
  • CPRX 2.9B
  • CALX 2.9B
  • IPO Year
  • CPRX 2006
  • CALX 2010
  • Fundamental
  • Price
  • CPRX $24.86
  • CALX $46.91
  • Analyst Decision
  • CPRX Strong Buy
  • CALX Strong Buy
  • Analyst Count
  • CPRX 7
  • CALX 5
  • Target Price
  • CPRX $32.29
  • CALX $47.40
  • AVG Volume (30 Days)
  • CPRX 1.1M
  • CALX 708.2K
  • Earning Date
  • CPRX 05-07-2025
  • CALX 07-21-2025
  • Dividend Yield
  • CPRX N/A
  • CALX N/A
  • EPS Growth
  • CPRX 178.13
  • CALX N/A
  • EPS
  • CPRX 1.57
  • CALX N/A
  • Revenue
  • CPRX $534,645,999.00
  • CALX $825,450,000.00
  • Revenue This Year
  • CPRX $16.37
  • CALX $10.66
  • Revenue Next Year
  • CPRX $8.80
  • CALX $9.99
  • P/E Ratio
  • CPRX $15.91
  • CALX N/A
  • Revenue Growth
  • CPRX 29.97
  • CALX N/A
  • 52 Week Low
  • CPRX $14.75
  • CALX $28.61
  • 52 Week High
  • CPRX $26.16
  • CALX $47.73
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 61.03
  • CALX 68.82
  • Support Level
  • CPRX $24.19
  • CALX $45.74
  • Resistance Level
  • CPRX $25.00
  • CALX $47.73
  • Average True Range (ATR)
  • CPRX 0.68
  • CALX 0.91
  • MACD
  • CPRX 0.07
  • CALX -0.27
  • Stochastic Oscillator
  • CPRX 90.18
  • CALX 57.64

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About CALX Calix Inc

Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.

Share on Social Networks: